Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
AVTX
Avalo Therapeutics, Inc.
NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close
$15.33
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
PHARMACEUTICAL PREPARATIONS
Market cap
$822.15M
Country
USA
RECENT INSIDER TRADES
2026-09-18
· Sullivan Christopher Ryan
(Chief Financial Officer)
· OTHER
2026-09-18
· Sullivan Christopher Ryan
(Chief Financial Officer)
· SELL
2026-09-11
· Sullivan Christopher Ryan
(Chief Financial Officer)
· OTHER
2026-09-11
· Sullivan Christopher Ryan
(Chief Financial Officer)
· SELL
2026-09-01
· Doyle Mittie
(Chief Medical Officer)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
129
Shares held
71,613,128
Value
$1.30B
Percent of shares outstanding
133.53%
As of quarter end
2026-06-30
RECENT NEWS
AVTX: Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Avalo Therapeutics to present at EADV 2026 Congress
Avalo Therapeutics presents phase 2 data at H.C. Wainwright conference
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Avalo Therapeutics, Inc. (AVTX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit